Reports
Reports
Unique mercury poisoning cases are creating revenue streams for healthcare companies in the mercury poisoning treatment market. For instance, in December 2019, it was reported that a women entered into comatose after using a skin-lightening cream of a world-renowned personal care brand, which was tainted with high levels of mercury. Such cases are increasing the demand for drugs induced with chelating agents and combination therapies in the mercury poisoning treatment market. As such, the market for mercury poisoning treatment is projected to expand at a favorable CAGR of ~5% during the forecast period.
Other key market drivers such as increased level of mercury emissions are fueling the demand for treatments involving combination therapy with chelating agents in the market for mercury poisoning treatment. It has been found that over the past several hundred years, mining and other human activities have released several million tons of mercury in the environment. Researchers at the David Streets of Argonne National Laboratory, U.S., stated that several pollutants, including mercury have not been sequestered naturally, and hence remain mobile in the environment causing new cases of mercury poisoning among individuals.
Researchers are using state-of-the-art methods to reinvestigate the historic Minamata mass mercury poisoning incident. For instance, researchers at the University of Saskatchewan (USask) are using novel techniques to study historic animal brain tissue samples to understand how mercury acts in the environment and affects humans. This is evident since individuals are prone to risks of exposure to mercury by the consumption of shellfish and fish items such as the Japanese delicacy Sushi.
Activities such as reassessment of species involved in other organic mercury poisoning incidents, such as in Grassy Narrows, Ontario, are surging in the mercury poisoning treatment market. This explains why the revenue of organic mercury poisoning dictates the highest share among all forms in the market for mercury poisoning treatment. The high incidence of impaired peripheral vision and muscle weakness due to mercury exposure are creating revenue opportunities for companies in the market for mercury poisoning treatment.
The high incidences of mercury poisoning are reported due to dental amalgams. These amalgams are traditionally made of a mix of mercury and a metal alloy that contains copper, silver or tin, which are used to fill dental cavities. Hence, scientists in the mercury poisoning treatment market are introducing mercury-free alternatives for fillings in order to reduce incidence of mercury exposure. Such innovative trends are boosting the revenue of the mercury poisoning treatment market, which is estimated to reach a value of ~US$ 50 Mn by the end of 2030.
Companies in the market for mercury poisoning treatment should collaborate with scientists to innovate in mercury-free alternatives for dental fillings. However, these alternative fillings are more expensive than traditional amalgams, which restricts its wide scale adoption in dental care settings. Hence, dental care practitioners in the market for mercury poisoning treatment are gaining efficacy in ultrasound, laser, and drug-based treatments to stimulate the regeneration of dentine.
Healthcare systems worldwide are prepared to evaluate and care for patients with COVID-19 (coronavirus) or are suspected to contact the novel virus. Since mercury emissions are already prevalent in the environment, hospitals are in daily contact with local, state, and federal agencies in order to stay uncompromised when situation arises to treat patients with mercury poisoning. Hospitals in the market for mercury poisoning treatment are adopting safety practices in situations where patients require emergency care.
Companies in the mercury poisoning treatment market are increasing their production capabilities in drugs such as chelating agents to avoid any shortages in medical supplies. They are placing a skeleton crew to organize these production activities. Manufacturers are increasing the availability of mercury-free alternatives for dental fillings in case of pediatric dental care emergency cases.
Analysts’ Viewpoint
Companies in the mercury poisoning treatment market are increasing the availability of drugs, especially involving chelating agents to meet emergency case requirements of individuals exposed to mercury amidst the COVID-19 outbreak. Researchers are leveraging their reinvestigation activities of historic animal species with the help of spectroscopy and sophisticated computational methods.
Mercury-free alternatives for dental fillings such as composite fillings, glass ionomer fillings, and gold inlays are creating revenue streams for dental practitioners. However, these alternatives are more expensive than traditional dental amalgams. Hence, healthcare companies should increase awareness about drug-based treatments and laser therapies that offset the risks involved with mercury poisoning.
The global mercury poisoning treatment market was worth US$ 32 Mn and is projected to reach a value of US$ 50 Mn by the end of 2030
Mercury poisoning treatment market is anticipated to grow at a CAGR of 5% during the forecast period
North America accounted for a major share of the global mercury poisoning treatment market
Mercury poisoning treatment market is driven by increased level of mercury emissions are fueling the demand for treatments involving combination therapy with chelating agents in the market for mercury poisoning treatment
Key players in the global mercury poisoning treatment market include Mylan N.V., Akorn, Incorporated, EmeraMed, Sanofi, Heyl Chemisch-pharmazeutische Fabrik GmbH Co. KG, Genex Pharma, and Recordati S.p.A. (Recordati Rare Diseases).
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Mercury Poisoning Treatment Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Mercury Poisoning Treatment Market Analysis and Forecast, 2018–2030
5. Market Outlook
5.1. Mercury Poisoning Overview
5.2. Research and Development Strategies & Pipeline Analysis
5.3. Treatment Cost - Global - By Key Regions
5.4. Drug Prices – Global - By Key Regions
5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short /Mid / Long-term Impact) Pricing Analysis
6. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug
6.1. Introduction & Definition
6.2. Global Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030
6.2.1. Chelating Agents
6.2.1.1. Dimercaprol or British anti-Lewisite (BAL)
6.2.1.2. Dimercaptosuccinic Acid (DMSA)
6.2.1.3. DMPS
6.2.1.4. Penicillamine
6.2.1.5. Others
6.2.2. Combination Therapy with Chelating Agents
6.2.3. Plasma Exchange Hemodialysis Plasmapheresis
6.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Drug
7. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type
7.1. Introduction & Definition
7.2. Global Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030
7.2.1. Acute Mercury Poisoning
7.2.2. Chronic Mercury Poisoning
7.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Type
8. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type
8.1. Introduction
8.2. Global Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030
8.2.1. Supportive Treatment
8.2.2. Antidotal Treatment
8.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Treatment Type
9. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form
9.1. Introduction
9.2. Global Mercury Poisoning Treatment Market Value Forecast, by Form, 2018–2030
9.2.1. Inorganic Mercury
9.2.2. Elemental Mercury
9.2.3. Organic Mercury
9.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Form
10. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration
10.1. Introduction
10.2. Global Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030
10.2.1. Injectable
10.2.2. Oral
10.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Route of Administration
11. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel
11.1. Introduction
11.2. Global Mercury Poisoning Treatment Market Value Forecast, by End-user, 2018–2030
11.2.1. Hospital Pharmacies
11.2.2. Online Pharmacies
11.2.3. Retail Pharmacies
11.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by End-user
12. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Region
12.1. Introduction
12.2. Global Mercury Poisoning Treatment Market Value Forecast, by Region, 2018–2030
12.2.1. North America
12.2.2. Europe
12.2.3. Asia Pacific
12.2.4. Latin America
12.2.5. Middle East & Africa
12.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Region
13. North America Mercury Poisoning Treatment Market Analysis and Forecast
13.1. Introduction
13.2. North America Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030
13.2.1. Chelating Agents
13.2.1.1. Dimercaprol or British anti-Lewisite (BAL)
13.2.1.2. Dimercaptosuccinic Acid (DMSA)
13.2.1.3. DMPS
13.2.1.4. Penicillamine
13.2.1.5. Others
13.2.2. Combination Therapy with Chelating Agents
13.2.3. Plasma Exchange Hemodialysis Plasmapheresis
13.3. North America Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030
13.3.1. Acute Mercury Poisoning
13.3.2. Chronic Mercury Poisoning
13.4. North America Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030
13.4.1. Supportive Treatment
13.4.2. Antidotal Treatment
13.5. North America Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030
13.5.1. Inorganic Mercury
13.5.2. Elemental Mercury
13.5.3. Organic Mercury
13.6. North America Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030
13.6.1. Injectable
13.6.2. Oral
13.7. North America Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030
13.7.1. Hospital Pharmacies
13.7.2. Online Pharmacies
13.7.3. Retail Pharmacies
13.8. North America Mercury Poisoning Treatment Market Value Forecast, by Country, 2018–2030
13.8.1. U.S.
13.8.2. Canada
13.9. North America Mercury Poisoning Treatment Market Attractiveness Analysis
13.9.1. By Drug
13.9.2. By Type
13.9.3. By Treatment Type
13.9.4. By Form
13.9.5. By Route of Administration
13.9.6. By Distribution Channel
13.9.7. By Country
14. Europe Mercury Poisoning Treatment Market Analysis and Forecast
14.1. Introduction
14.2. Europe Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030
14.2.1. Chelating Agents
14.2.1.1. Dimercaprol or British anti-Lewisite (BAL)
14.2.1.2. Dimercaptosuccinic Acid (DMSA)
14.2.1.3. DMPS
14.2.1.4. Penicillamine
14.2.1.5. Others
14.2.2. Combination Therapy with Chelating Agents
14.2.3. Plasma Exchange Hemodialysis Plasmapheresis
14.3. Europe Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030
14.3.1. Acute Mercury Poisoning
14.3.2. Chronic Mercury Poisoning
14.4. Europe Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030
14.4.1. Supportive Treatment
14.4.2. Antidotal Treatment
14.5. Europe Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030
14.5.1. Inorganic Mercury
14.5.2. Elemental Mercury
14.5.3. Organic Mercury
14.6. Europe Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030
14.6.1. Injectable
14.6.2. Oral
14.7. Europe Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030
14.7.1. Hospital Pharmacies
14.7.2. Online Pharmacies
14.7.3. Retail Pharmacies
14.8. Europe Mercury Poisoning Treatment Market Value Forecast, by Country/Sub-region, 2018–2030
14.8.1. Germany
14.8.2. U.K.
14.8.3. France
14.8.4. Spain
14.8.5. Italy
14.8.6. Rest of Europe
14.9. Europe Mercury Poisoning Treatment Market Attractiveness Analysis
14.9.1. By Drug
14.9.2. By Type
14.9.3. By Treatment Type
14.9.4. By Form
14.9.5. By Route of Administration
14.9.6. By Distribution Channel
14.9.7. By Country/Sub-region
15. Asia Pacific Mercury Poisoning Treatment Market Analysis and Forecast
15.1. Introduction
15.2. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030
15.2.1. Chelating Agents
15.2.1.1. Dimercaprol or British anti-Lewisite (BAL)
15.2.1.2. Dimercaptosuccinic Acid (DMSA)
15.2.1.3. DMPS
15.2.1.4. Penicillamine
15.2.1.5. Others
15.2.2. Combination Therapy with Chelating Agents
15.2.3. Plasma Exchange Hemodialysis Plasmapheresis
15.3. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030
15.3.1. Acute Mercury Poisoning
15.3.2. Chronic Mercury Poisoning
15.4. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030
15.4.1. Supportive Treatment
15.4.2. Antidotal Treatment
15.5. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030
15.5.1. Inorganic Mercury
15.5.2. Elemental Mercury
15.5.3. Organic Mercury
15.6. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030
15.6.1. Injectable
15.6.2. Oral
15.7. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030
15.7.1. Hospital Pharmacies
15.7.2. Online Pharmacies
15.7.3. Retail Pharmacies
15.8. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Country/Sub-region, 2018–2030
15.8.1. Japan
15.8.2. China
15.8.3. India
15.8.4. Australia & New Zealand
15.8.5. Rest of Asia Pacific
15.9. Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis
15.9.1. By Drug
15.9.2. By Type
15.9.3. By Treatment Type
15.9.4. By Form
15.9.5. By Route of Administration
15.9.6. By Distribution Channel
15.9.7. By Country/Sub-region
16. Latin America Mercury Poisoning Treatment Market Analysis and Forecast
16.1. Introduction
16.2. Latin America Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030
16.2.1. Chelating Agents
16.2.1.1. Dimercaprol or British anti-Lewisite (BAL)
16.2.1.2. Dimercaptosuccinic Acid (DMSA)
16.2.1.3. DMPS
16.2.1.4. Penicillamine
16.2.1.5. Others
16.2.2. Combination Therapy with Chelating Agents
16.2.3. Plasma Exchange Hemodialysis Plasmapheresis
16.3. Latin America Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030
16.3.1. Acute Mercury Poisoning
16.3.2. Chronic Mercury Poisoning
16.4. Latin America Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030
16.4.1. Supportive Treatment
16.4.2. Antidotal Treatment
16.5. Latin America Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030
16.5.1. Inorganic Mercury
16.5.2. Elemental Mercury
16.5.3. Organic Mercury
16.6. Latin America Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030
16.6.1. Injectable
16.6.2. Oral
16.7. Latin America Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030
16.7.1. Hospital Pharmacies
16.7.2. Online Pharmacies
16.7.3. Retail Pharmacies
16.8. Latin America Mercury Poisoning Treatment Market Value Forecast, by Country/Sub-region, 2018–2030
16.8.1. Brazil
16.8.2. Mexico
16.8.3. Rest of Latin America
16.9. Latin America Mercury Poisoning Treatment Market Attractiveness Analysis
16.9.1. By Drug
16.9.2. By Type
16.9.3. By Treatment Type
16.9.4. By Form
16.9.5. By Route of Administration
16.9.6. By Distribution Channel
16.9.7. By Country/Sub-region
17. Middle East & Africa Mercury Poisoning Treatment Market Analysis and Forecast
17.1. Introduction
17.2. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030
17.2.1. Chelating Agents
17.2.1.1. Dimercaprol or British anti-Lewisite (BAL)
17.2.1.2. Dimercaptosuccinic Acid (DMSA)
17.2.1.3. DMPS
17.2.1.4. Penicillamine
17.2.1.5. Others
17.2.2. Combination Therapy with Chelating Agents
17.2.3. Plasma Exchange Hemodialysis Plasmapheresis
17.3. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030
17.3.1. Acute Mercury Poisoning
17.3.2. Chronic Mercury Poisoning
17.4. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030
17.4.1. Supportive Treatment
17.4.2. Antidotal Treatment
17.5. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030
17.5.1. Inorganic Mercury
17.5.2. Elemental Mercury
17.5.3. Organic Mercury
17.6. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030
17.6.1. Injectable
17.6.2. Oral
17.7. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030
17.7.1. Hospital Pharmacies
17.7.2. Online Pharmacies
17.7.3. Retail Pharmacies
17.8. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Country/Sub-region, 2018–2030
17.8.1. GCC Countries
17.8.2. South Africa
17.8.3. Rest of Middle East & Africa
17.9. Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis
17.9.1. By Drug
17.9.2. By Type
17.9.3. By Treatment Type
17.9.4. By Form
17.9.5. By Route of Administration
17.9.6. By Distribution Channel
17.9.7. By Country/Sub-region
18. Competition Landscape
18.1. Market Player - Competition Matrix (By Tier and Size of companies)
18.2. Global Mercury Poisoning Treatment Market Position Analysis, by Company, 2019
18.3. Company Profiles
18.3.1. Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
18.3.1.1. Company Description
18.3.1.2. Business Overview
18.3.1.3. Strategic Overview
18.3.1.4. SWOT Analysis
18.3.2. Genex Pharma
18.3.2.1. Company Description
18.3.2.2. Business Overview
18.3.2.3. Strategic Overview
18.3.2.4. SWOT Analysis
18.3.3. RECORDATI S.p.A. (Recordati Rare Diseases)
18.3.3.1. Company Description
18.3.3.2. Business Overview
18.3.3.3. Financial Overview
18.3.3.4. Strategic Overview
18.3.3.5. SWOT Analysis
18.3.4. Mylan N.V.
18.3.4.1. Company Description
18.3.4.2. Business Overview
18.3.4.3. Strategic Overview
18.3.4.4. Financial Overview
18.3.4.5. SWOT Analysis
18.3.5. Akorn, Incorporated
18.3.5.1. Company Description
18.3.5.2. Business Overview
18.3.5.3. Strategic Overview
18.3.5.4. Financial Overview
18.3.5.5. SWOT Analysis
18.3.6. EmeraMed Limited
18.3.6.1. Company Description
18.3.6.2. Business Overview
18.3.6.3. SWOT Analysis
18.3.7. Sanofi
18.3.7.1. Company Description
18.3.7.2. Business Overview
18.3.7.3. Strategic Overview
18.3.7.4. SWOT Analysis
List of Tables
Table 01 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030
Table 02 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030
Table 03 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 04 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type 2018–2030
Table 05 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030
Table 06 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 07 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 08 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 09 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 10 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030
Table 11 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030
Table 12 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 13 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 14 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030
Table 15 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 16 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 17 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 18 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030
Table 19 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030
Table 20 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 21 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 22 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030
Table 23 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 24 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 25 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 26 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030
Table 27 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030
Table 28 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 29 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 30 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030
Table 31 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 32 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 33 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 34 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030
Table 35 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030
Table 36 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 37 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 38 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030
Table 39 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 40 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 41 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 42 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030
Table 43 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030
Table 44 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 45 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 46 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030
Table 47 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 48 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
List of Figures
Figure 01 Global Mercury Poisoning Treatment Market Size (US$ Mn) Forecast, 2018–2030
Figure 02 Global Mercury Poisoning Treatment Market Value Share Analysis, by Drug, 2019 and 2030
Figure 03 Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Drug, 2020–2030
Figure 04 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Chelating Agents, 2018–2030
Figure 05 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Combination Therapy with Chelating Agents, 2018–2030
Figure 06 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Plasma Exchange Hemodialysis Plasmapheresis, 2018–2030
Figure 07 Global Mercury Poisoning Treatment Market Value Share Analysis, by Type, 2019 and 2030
Figure 08 Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Type, 2020–2030
Figure 09 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Acute Mercury Poisoning, 2018–2030
Figure 10 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Chronic Mercury Poisoning, 2018–2030
Figure 11 Global Mercury Poisoning Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2030
Figure 12 Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Treatment Type, 2020–2030
Figure 13 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Supportive Treatment, 2018–2030
Figure 14 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Antidotal Treatment, 2018–2030
Figure 15 Global Mercury Poisoning Treatment Market Value Share Analysis, by Form, 2019 and 2030
Figure 16 Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Form, 2020–2030
Figure 17 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Inorganic Mercury, 2018–2030
Figure 18 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Elemental Mercury, 2018–2030
Figure 19 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Organic Mercury, 2018–2030
Figure 20 Global Mercury Poisoning Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030
Figure 21 Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030
Figure 22 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Injectable, 2018–2030
Figure 23 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Oral, 2018–2030
Figure 24 Global Mercury Poisoning Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 25 Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 26 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospital Pharmacies, 2018–2030
Figure 27 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Online Pharmacies, 2018–2030
Figure 28 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Retail Pharmacies, 2018–2030
Figure 29 Global Mercury Poisoning Treatment Market Value Share Analysis, by Region, 2019 and 2030
Figure 30 Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Region, 2020–2030
Figure 31 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, 2018–2030
Figure 32 North America Mercury Poisoning Treatment Market Value Share Analysis, by Country, 2019 and 2027
Figure 33 North America Mercury Poisoning Treatment Market Attractiveness Analysis, by Country, 2020–2030
Figure 34 North America Mercury Poisoning Treatment Market Value Share Analysis, by Drug, 2019 and 2030
Figure 35 North America Mercury Poisoning Treatment Market Attractiveness Analysis, by Drug, 2020–2030
Figure 36 North America Mercury Poisoning Treatment Market Value Share Analysis, by Type, 2019 and 2030
Figure 37 North America Mercury Poisoning Treatment Market Attractiveness Analysis, by Type, 2020–2030
Figure 38 North America Mercury Poisoning Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2030
Figure 39 North America Mercury Poisoning Treatment Market Attractiveness Analysis, by Treatment Type, 2020–2030
Figure 40 North America Mercury Poisoning Treatment Market Value Share Analysis, by Form, 2019 and 2030
Figure 41 North America Mercury Poisoning Treatment Market Attractiveness Analysis, by Form, 2020–2030
Figure 42 North America Mercury Poisoning Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030
Figure 43 North America Mercury Poisoning Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030
Figure 44 North America Mercury Poisoning Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 45 North America Mercury Poisoning Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 46 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, 2018–2030
Figure 47 Europe Mercury Poisoning Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
Figure 48 Europe Mercury Poisoning Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 49 Europe Mercury Poisoning Treatment Market Value Share Analysis, by Drug, 2019 and 2030
Figure 50 Europe Mercury Poisoning Treatment Market Attractiveness Analysis, by Drug, 2020–2030
Figure 51 Europe Mercury Poisoning Treatment Market Value Share Analysis, by Type, 2019 and 2030
Figure 52 Europe Mercury Poisoning Treatment Market Attractiveness Analysis, by Type, 2020–2030
Figure 53 Europe Mercury Poisoning Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2030
Figure 54 Europe Mercury Poisoning Treatment Market Attractiveness Analysis, by Treatment Type, 2020–2030
Figure 55 Europe Mercury Poisoning Treatment Market Value Share Analysis, by Form, 2019 and 2030
Figure 56 Europe Mercury Poisoning Treatment Market Attractiveness Analysis, by Form, 2020–2030
Figure 57 Europe Mercury Poisoning Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030
Figure 58 Europe Mercury Poisoning Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030
Figure 59 Europe Mercury Poisoning Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 60 Europe Mercury Poisoning Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 61 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, 2018–2030
Figure 62 Asia Pacific Mercury Poisoning Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
Figure 63 Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 64 Asia Pacific Mercury Poisoning Treatment Market Value Share Analysis, by Drug, 2019 and 2030
Figure 65 Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis, by Drug, 2020–2030
Figure 66 Asia Pacific Mercury Poisoning Treatment Market Value Share Analysis, by Type, 2019 and 2030
Figure 67 Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis, by Type, 2020–2030
Figure 68 Asia Pacific Mercury Poisoning Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2030
Figure 69 Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis, by Treatment Type, 2020–2030
Figure 70 Asia Pacific Mercury Poisoning Treatment Market Value Share Analysis, by Form, 2019 and 2030
Figure 71 Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis, by Form, 2020–2030
Figure 72 Asia Pacific Mercury Poisoning Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030
Figure 73 Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030
Figure 74 Asia Pacific Mercury Poisoning Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 75 Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 76 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, 2018–2030
Figure 77 Latin America Mercury Poisoning Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
Figure 78 Latin America Mercury Poisoning Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 79 Latin America Mercury Poisoning Treatment Market Value Share Analysis, by Drug, 2019 and 2030
Figure 80 Latin America Mercury Poisoning Treatment Market Attractiveness Analysis, by Drug, 2020–2030
Figure 81 Latin America Mercury Poisoning Treatment Market Value Share Analysis, by Type, 2019 and 2030
Figure 82 Latin America Mercury Poisoning Treatment Market Attractiveness Analysis, by Type, 2020–2030
Figure 83 Latin America Mercury Poisoning Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2030
Figure 84 Latin America Mercury Poisoning Treatment Market Attractiveness Analysis, by Treatment Type, 2020–2030
Figure 85 Latin America Mercury Poisoning Treatment Market Value Share Analysis, by Form, 2019 and 2030
Figure 86 Latin America Mercury Poisoning Treatment Market Attractiveness Analysis, by Form, 2020–2030
Figure 87 Latin America Mercury Poisoning Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030
Figure 88 Latin America Mercury Poisoning Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030
Figure 89 Latin America Mercury Poisoning Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 90 Latin America Mercury Poisoning Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 91 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, 2018–2030
Figure 92 Middle East & Africa Mercury Poisoning Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
Figure 93 Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 94 Middle East & Africa Mercury Poisoning Treatment Market Value Share Analysis, by Drug, 2019 and 2030
Figure 95 Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis, by Drug, 2020–2030
Figure 96 Middle East & Africa Mercury Poisoning Treatment Market Value Share Analysis, by Type, 2019 and 2030
Figure 97 Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis, by Type, 2020–2030
Figure 98 Middle East & Africa Mercury Poisoning Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2030
Figure 99 Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis, by Treatment Type, 2020–2030
Figure 100 Middle East & Africa Mercury Poisoning Treatment Market Value Share Analysis, by Form, 2019 and 2030
Figure 101 Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis, by Form, 2020–2030
Figure 102 Middle East & Africa Mercury Poisoning Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030
Figure 103 Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030
Figure 104 Middle East & Africa Mercury Poisoning Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 105 Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Mercury Poisoning Treatment Market